Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vincent Chung
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
534 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- the University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills - Peninsula Hospitals
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Kaiser Permanente Hospital
Fontana, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Kaiser Permanente
Fresno, California, United States
- Saint Jude Medical Center
Fullerton, California, United States
- Kaiser Permanente - Harbor City
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente-Cadillac
Los Angeles, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Mercy Uc Davis Cancer Center
Merced, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- El Camino Hospital
Mountain View, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Hematology and Oncology Associates-Oakland
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Tom K Lee Inc
Oakland, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 30 Jun 2015
- Completion
- 30 Jun 2015
- Last update posted
- 9 Mar 2016
- Registered enrollment
- 137
- Registry id
- NCT01658943
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.